Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology

JCI Insight

Volumn 1, Issue 6, 2016, Pages

  Harrison, Stephanie R ^a   McGonagle, Dennis ^a   Nizam, Sharmin ^b   Jarrett, Stephen ^b   van der Hilst, Jeroen ^c,d   McDermott, Michael F ^a   Savic, Sinisa ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

^c JESSA HOSPITAL   (Belgium)

^d HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85055604983     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/jci.insight.86336     Document Type: Article

References (27)

1. Savic S, Dickie LJ, Wittmann M, McDermott MF. Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives. Best Pract Res Clin Rheumatol. 2012; 26(4):505-533.
2. Lachmann HJ. Clinical immunology review series: An approach to the patient with a periodic fever syndrome. Clin Exp Immunol. 2011; 165(3):301-309.
3. Martinon F, Aksentijevich I. New players driving inflammation in monogenic autoinflammatory diseases. Nat Rev Rheumatol. 2015; 11(1):11-20.
4. Aksentijevich I. Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years. Semin Immunopathol. 2015; 37(4):395-401.
5. Rigante D, Vitale A, Lucherini OM, Cantarini L. The hereditary autoinflammatory disorders uncovered. Autoimmun Rev. 2014; 13(9):892-900.
6. Cantarini L, et al. The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy. Clin Rheumatol. 2015; 34(1):17-28.
7. Mahroum N, Mahagna H, Amital H. Diagnosis and classification of adult Still's disease. J Autoimmun. 2014; 48-49:34-37.
8. Koné-Paut I, Galeotti C. Anakinra for cryopyrin-associated periodic syndrome. Exp Rev Clin Immunol. 2014; 10(1):7-18.
9. Hoffman HM, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004; 364(9447):1779-1785.
10. Goldbach-Mansky R, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. N Engl J Med. 2006; 355(6):581-592.
11. Hoffman HM, et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum. 2008; 58(8):2443-2452.
12. Lachmann HJ, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009; 360(23):2416-2425.
13. Gattorno M, et al. Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2008; 58(5):1516-1520.
14. Yamaguchi M, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992; 19(3):424-430.
15. Savic S, McDermott MF. Clinical genetics in 2014: New monogenic diseases spanning the immunological disease continuum. Nat Rev Rheumatol. 2014; 11(2):67-68.
16. McDermott MF, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999; 97(1):133-144.
17. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006; 3(8):e297.
18. Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol. 2011; 41(5):1203-1217.
19. Wittmann M, Kingsbury SR, McDermott MF. Is caspase 1 central to activation of interleukin-1? Joint Bone Spine. 2011; 78(4):327-330.
20. Adamopoulos IE. Autoimmune or autoinflammatory? Bad to the bone. Int J Clin Rheumatol. 2015; 10(1):5-7.
21. Finetti M, et al. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr. 2014; 164(6):1425-1431.
22. Emmi G, et al. Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study. [published online ahead of print July 10, 2015]. Clin Rheumatol. doi:10.1007/s10067-015-3004-0.
23. Giannelou A, Zhou Q, Kastner DL. When less is more: primary immunodeficiency with an autoinflammatory kick. Curr Opin Allergy Clin Immunol. 2014; 14(6):491-500.
24. Sokumbi O, Drage LA, Peters MS. Clinical and histopathologic review of Schnitzler syndrome: The Mayo Clinic experience (1972-2011). J Am Acad Dermatol. 2012; 67(6):1289-1295.
25. Efthimiou P, Moorthy LN, Mavragani CP, Skokos D, Fautrel B. Adult onset Still's disease and autoinflammation. Int J Inflam. 2012; 2012:964751.
26. Hong D, Yang Z, Han S, Liang X, Ma K, Zhang X. Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety. Drug Des Devel Ther. 2014; 8:2345-2357.
27. Zhou Q, et al. Brief report: cryopyrin-associated periodic syndrome caused by a myeloid-restricted somatic NLRP3 mutation. Arthritis Rheumatol. 2015; 67(9):2482-2486.